Adherence with the use of clearance techniques

Therapy for Mucus-Clearance Disorders

Volumn , Issue , 2004, Pages 105-128

  Abbott, Janice ^a   Dodd, Mary E ^b   Webb, A Kevin ^b  

^a UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^b WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856851610     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (93)

1. van der Schans CP. Forced expiratory manoeuvres to increase transport of bronchial mucus: a mechanistic approach. Monaldi Arch Chest Dis 1997; 52:367-370.
2. Sutton PP, Parker RA, Webber BA. Assessment of the forced expiration technique, postural drainage, and directed coughing in chest physiotherapy. Eur J Respir Dis1983; 64:62.
3. Hasani A. Pavia D, Agnew JE, Clarke SW. The effect of unproductive coughing/FET on regional mucus movement in the human lungs. Respir Med 1991; 85: 23-26.
4. Lannefors L, Wollmer P. Mucus clearance with three chest physiotherapy regimes in cystic fibrosis: a comparison between postural drainage, PEP and exercise. Eur Respir J 1992; 5:748-753.
5. Cemy FJ, Relative effects of bronchial drainage and exercise for in-hospital care of patients with cystic fibrosis. Phys Ther 1989; 69:633-639.
6. Bilton D, Dodd M, Abbott J, Webb AK. The benefits of exercise combined with physiotherapy in the treatment of adults with cystic fibrosis. Respir Med 1992; 86: 507-511.
7. Rossman C, Waldes R, Sampson D, Newhouse M. Effect of chest physiotherapy on the removal of mucus in patients with cystic fibrosis. Am Rev Respir Dis 1982; 120:131-135.
8. Webber BA, Hofmeyr JL, Morgan MDL, Hodson ME. Effects of postural drainage, incorporating the forced expiratory technique, on pulmonary function in cystic fibrosis. Br J Dis Chest 1986; 80:353-359.
9. Currie DC. Munro C, Gaskell D, Cole PJ. Practice, problems and compliance with postural drainage: a survey of chronic sputum producers. Br J Dis Chest 1986; 80: 249-253.
10. Prasad SA, Main E. Finding evidence to support airway clearance techniques in cystic fibrosis. Disabil Rehabil 1998; 20:235-246.
11. Patterson JM, Budd J, Goetz D, Warwick W J. Family correlates of a 10 year pulmonary health trend in cystic fibrosis. Pediatrics 1993; 91:383-389.
12. Horwitz RI, Horwitz SM. Adherence to treatment and health outcomes. Arch Intern Med 1993; 153:1863-1868.
13. Sackett DL, Snow JC. The magnitude of compliance and non-compliance. In: Haynes RB, Taylor DW, Sacket DL, eds. Compliance in Health Care. Baltimore, MD: John Hopkins University Press, 1979:11-22.
14. Abbott J, Dodd M. Bilton D, Webb AK. Treatment compliance in adults with cystic fibrosis. Thorax 1994; 49:115-120.
15. Pownceby J. The Coming of Age Project: A Study of the Transition from Paediatric to Adult Care and Treatment Adherence Amongst Young People with Cystic Fibrosis. Bromley, Kent, UK: Cystic Fibrosis Trust, 1996.
16. Passero MA, Remor B, Salomon J. Patient-reported compliance with cystic fibrosis therapy. Clin Pediatr 1981; 20:264-268.
17. Shepherd SL, Hovel MF, Harwood IR, Granger LE, Hofstettew CR, Molgaard C, Kaplan RM. A comparative study of the psychosocial assets of adults with cystic fibrosis and their healthy peers. Chest 1990; 97:1310-1316.
18. Conway S, Pond M N, Hamnett T, Watson A. Compliance with treatment in adult patients with cystic fibrosis. Thorax 1996; 51:29-33.
19. Sluijs EM, Kok GJ, van der Zee J. Correlates of exercise compliance in physical therapy. Phys Ther 1993; 73:771-782.
20. Kaplan RM, Sallis JF, Patterson TL. Health and Human Behavior. New York: McGraw-Hill, 1993.
21. Royal Pharmacological Society of Great Britian/Merck Sharpe and Dohme. From Compliance to Concordance. Achieving Shared Goals in Medicine Taking. London, 1997.
22. Gordis L, Markowitz PHM, Lilienfield AM. The inaccuracy in using interviews to estimate patient reliability in taking medications at home. Med Care 1969; 7: 49-54.
23. Maenpaa H, Javela K, Pikkarainan J, Malkone M, Heinonen OP, Manninen V. Minimal doses of digoxin: a new marker for compliance to medication. Eur Heart J 1987; 8:31-37.
24. Wright EC. Non-compliance-or how many aunts has Matilda? Lancet 1993; 342: 909-913.
25. Litt IF, Cuskey WR. Compliance with medical regimens during adolescence. Pediatr Clin North Am 1980; 27:3-15.
26. Epstein LH, Cluss PA. A behavioural medicine perspective on adherence to longterm medical regimens. J Consult Clin Psychol 1982: 50:950-971.
27. Ley P. Satisfaction, compliance and communication. Br J Clin Psychol 1982; 21: 241-254.
28. Dodd ME, Haworth CS, Moorcroft AJ, Miles J, Webb AK. Is medicine evidenced-based when there is discrepancy between patient reported and objective measures of compliance in clinical trials? Pediatr Pulmonol 1998; 17:398.
29. Fletcher RH. Patient compliance with therapeutic advice: a modern view. Mount Sinai J Med 1989; 56:453-457.
30. Spector SL, Kinsman R, Mawhinney H. Compliance of patients with an experimental aerosolised medication: implications for controlled clinical trials. J. Allergy Clin Immunol 1986: 66:65-70.
31. Chowienczyk PJ, Parkin DH. Lawson CP, Cochrane GM. Do asthmatic patients correctly record home spirometry measurements? Br Med J 1994; 309:1618.
32. Wonham K, Jenkins J, Pillinger J, Jones K. Compliance with completing peak flow charts. Asthma Gen Pract 1996; 4:7-8.
33. Ley P. Communicating with Patients. London: Croom Helm. 1988.
34. McColley SA, Boas SR, Jain M, Qualter NA, O'Malley CA. Patient adherence to and treatment satisfaction with an airway clearance technique. Pediatr Pulmonol1998; (suppl 17) 389.
35. Czajkowski DR, Koocher GP. Predicting medical compliance among adolescents with cystic fibrosis. Health Psychol 1986; 5:297-305.
36. Angst DB, Deatrick JA. Involvement in health care decisions: parents and children with chronic illness. J Family Nurs 1996; 2:174-194.
37. Steen HJ, Redmond AOB, O’Neill D, Beattie F. Evaluation of the PEP mask in cystic fibrosis. Acta Paediatr Scand 1991; 80:51-56.
38. Strauss GD, Wellisch DK. Psychological adaptation in older cystic fibrosis patients. J Chronic Dis 1981; 34:141-146.
39. Czajkowski D, Koocher G. Medical compliance and coping with cystic fibrosis. J Child Psychol Psychiatry 1987; 23:311-319.
40. Patterson JM. Critical factors affecting family compliance with home treatment for children with cystic fibrosis. Family Relat 1985; 34:79-89.
41. Meichenbaum D, Turk DC. Facilitating Treatment Adherence. New York: Plenum Press, 1987.
42. Meyers A, Dolan TF, Mueller D. Compliance and self-medication in cystic fibrosis. Am J Dis Child 1975; 129:1011-1013.
43. Eigen H, Clark NM, Wolle JM. Clinical-behavioral aspects of cystic fibrosis: directions for future research. Am Rev Respir Dis 1987; 136: 1509-1513.
44. Friedman IM, Litt IF. Promoting adolescents’ compliance with therapeutic regimens. Pediatr Clin North Am 1986; 33:955-973.
45. McCracken M J. Cystic fibrosis in adolescence. In: Blum R, ed. Chronic Illness and Disabilities in Childhood and Adolescence. New York: Grune &Stratton, 1984.
46. Denning CR, Gluckson MM. Psychosocial aspects of cystic fibrosis. In: Taussig LM, ed. Cystic Fibrosis. New York: Thieme-Stratton, 1984.
47. Quirk FH, Jones PW. Patients’ perception of distress due to symptoms and effects of asthma on daily living and an investigation of possible influential factors. Clin Sci 1990; 79:17-21.
48. Dugdale A. Non-compliance or rational decision? Lancet 1993; 342:1426-1427.
49. Patterson JM. A family systems perspective for working with youth with disability. Pediatrician 1991; 18:129-141.
50. Giess S, Hobbs S, Hannersley-Maercklein G, Kramer J, Henley M. Psychosocial factors related to perceived compliance with cystic fibrosis treatment. J Clin Psychol 1992; 48:99-103.
51. Deaton AV. Adaptive non-compliance in pediatric asthma: the parent as expert. J Pediatr Psychol 1985; 10:1-14.
52. Koocher GP, McGrath ML, Gudas LJ. Typologies of non-adherence in cystic fibrosis. Dev Behav Pediatr 1990; 11:353-358.
53. Lask B. Non-adherence to treatment in cystic fibrosis. J Roy Soc Med 1994; 87: 25-28.
54. Douthitt VL. Psychological determinants of adolescent exercise adherence. Adolescence 1994; 29:711-722.
55. Levison H. Tabachnik E. Pulmonary physiology. In: Hodson ME, Norman AP, Batten JC, eds. Cystic Fibrosis. London: Bailliere Tindall, 1983:52-81.
56. Conway SP, Pond MN, Watson A, Hamnett T. Knowledge of adult patients with cystic fibrosis about their illness. Thorax 1996; 51:34-38.
57. Dodd ME, Unsworth R, Davis A, Webb AK. Individualised teaching improves knowledge and adherence with airway clearance techniques. Pediatr Pulmonol1998; (suppl 17):346.
58. Tebbi C, Cummings M, Zevon M, Smith L. Richards M, Malion J. Compliance of pediatric and adolescent cancer patients. Cancer 1986; 58:1179-1184.
59. Christiaanse M, Lavigne J, Lemer C. Psychosocial aspects of compliance in children and adolescents with asthma. J Dev Behav Pediatr 1989: 10:75-80.
60. Abbott J, Dodd M, Webb AK. Different perceptions of disease severity and self care between patients with cystic fibrosis, their close companion, and physician. Thorax 1995; 50:794-796.
61. Gudas LJ, Koocher GP, Wypij D. Perceptions of medical compliance in children and adolescents with cystic fibrosis. Dev Behav Pediatr 1991; 12:236-242.
62. Muszynski-Kwan AT, Perlman R, Rivington-Law BA. Compliance with and effectiveness of chest physiotherapy in cystic fibrosis: a review. Physiother Canada1988: 40:28-32.
63. Mcllwaine MP, Davidson GF. Airway clearance techniques in the treatment of cystic fibrosis. Curr Opin Pulm Med 1996; 2:447-451.
64. Becker MH. The Health Belief Model and Personal Health Behavior. Thorofare, NJ: Slack, 1974.
65. Abbott J, Dodd M, Webb AK. Health perceptions and treatment adherence in adults with cystic fibrosis. Thorax 1996; 51:1233-1238.
66. Kirscht JP, Rosenstock IM. Patient adherence to antihypertensive medical regimens. J Commun Health 1977; 3:115-124.
67. Hartman PE. Becker MH. Non-compliance with prescribed regimen among chronic hemodialysis patients. Dial Transplant 1978; 7:978-985.
68. Becker M, Kabak M, Rosenstock I, Ruth M. Some influences of public participation in a genetic screening program. J Commun Health 1975; 1:3-14.
69. Hochbaum G. Why people seek diagnostic x-rays. Public Health Rep 1956; 71: 377-380.
70. Champion V. Use of the health belief model in determining frequency of breast self-examination. Res Nurs Health 1985; 8:373-379.
71. Moise JR, Drotar D, Doershuk CF, Stem RC. Correlates of psychosocial adjustment among young adults with cystic fibrosis. Dev Behav Pediatr 1987; 8:141-148.
72. Scheier MF, Carver CS. Optimism, coping and health: assessment and implications of generalised outcome expectancies. Health Psychol 1985; 4:219-247.
73. Abbott J, Dodd M, Gilling S, Webb AK. Coping styles and treatment adherence in adults with cystic fibrosis. 21st European Cystic Fibrosis Conference, Davos, Switzerland, 1997.
74. Chmelik F, Doughty A. Objective measurements of compliance in asthma treatment. Ann Allergy 1994; 73:527-532.
75. McCracken MJ, Budd J, Warick W. A study of self care intervention for adolescents with cystic fibrosis. Pediatr Pulmonol 1992; S8:114-115.
76. Bartholomew LK, Sockrider MM, Seilheimer DK. Czyzewski DI, Parcel GS, Spinelli SH. Performance objectives for the self-management of cystic fibrosis. Patient Ed Counsel 1993; 22:15-25.
77. Cottrell CK, Young GA, Creer TL, Holroyd KA, Kotses H. The development and evaluation of a self-management programme for cystic fibrosis. Pediatr Asthma Allergy Immunol 1996; 10:109-118.
78. Kiecolt-Glaser JK, Glaser R. Psychological influences on immunity. Psychosomat-ics 1986; 27:621-624.
79. Kiecolt-Glaser JK, Stephens RE. Lipetz PD, Speicher CE, Glaser R. Distress and DNA repair in human lymphocytes. J Behav Med 1985; 8:311-320.
80. McKinney ME, Hofschire PJ, Buell JC, Eliot RS. Hemodynamic and biochemical responses to stress: the necessary link between type A behavior and cardiovascular disease. Behav Med Update 1984; 6:16-21.
81. Spiegel D, Bloom JR, Kraemer HC, Gottheil E. Effect of psychosocial treatment on survival of patients with metastic breast cancer. Lancet 1989; 334:888-891.
82. Greer S, Moorey S, Baruch JDR. Watson M, Robertson BM, Mason A, Rowden L, Law M G, Bliss JM. Adjuvant psychological therapy for patients with cancer: a prospective randomised trial. Br Med J 1992; 304:675-680.
83. Berkman LF, Syme SL. Social networks, host resistance and mortality: a nine year follow-up study of Alameda County residents. Am J Epidemiol 1979; 109:186-204.
84. Kaplan GA, Wilson TW. Cohen RD, Kauhanen J, Wu M. Salonen JT. Social functioning and overall mortality: prospective evidence from the Kuopio Ischemic Heart Disease Risk Factor Study. Epidemiology 1994; 5:495-500.
85. Taylor AH. Evaluating GP exercise prescription schemes: findings from a randomised control trial. Brighton, UK: Chelsea School Research Centre, University of Brighton, 1996.
86. Bandura A. Self-efficacy: toward a unifying theory of behavioural change. Psychol Rev 1977; 84:191-215.
87. Zimmerman BW, Brown ST, Bowman JM. A self-management programme for chronic obstructive pulmonary disease: relationship to dyspnea and self-efficacy. Rehab Nurs 1996; 21:253-257.
88. Wigal J, Creer T, Kotses H. The COPD self-efficacy Scale. Chest 1991; 99: 1193-1196.
89. Kaplan R, Atkins C, Reinsch S. Specific efficacy expectations mediate exercise compliance in patients with COPD. Health Psychol 1984; 3:223-242.
90. Scherer YK, Schmieder LE. The effect of a pulmonary rehabilitation programme on self-efficacy, perception of dyspnea, and physical endurance. Heart Lung 1997: 26:15-22.
91. Rapoff MA, Christopherson ER. Compliance of paediatric patients with medical regimens: a review and evaluation. In: Stuart RB, ed. Adherence. Compliance and Generalization in Behavioral Medicine. New York: Brunner/Mazel, 1982.
92. Pryor JA, Webber BA, Hodson ME, Warner JO. The Flutter VRPI as an adjunct to chest physiotherapy in cystic fibrosis. Respir Med 1994: 88:677-681.
93. Mcllwaine MP, Wong LT, Peacock D, Davidson GF. Long-term comparative trial of conventional postural drainage and percussion versus positive expiratory pressure physiotherapy in the treatment of cystic fibrosis. J. Pediatr 1997; 131:570-573.